Vilariño N - Search Results

1

FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.

Bernat-Peguera A, Navarro-Ventura J, Lorenzo-Sanz L, da Silva-Diz V, Bosio M, Palomero L, Penin RM, Pérez Sidelnikova D, Bermejo JO, Taberna M, Vilariño N, Piulats JM, Mesia R, Viñals JM, González-Suárez E, Capella-Gutierrez S, Villanueva A, Viñals F, Muñoz P. Bernat-Peguera A, et al. Among authors: vilarino n. Clin Cancer Res. 2021 Mar 1;27(5):1491-1504. doi: 10.1158/1078-0432.CCR-20-0232. Epub 2020 Dec 1. Clin Cancer Res. 2021. PMID: 33262138

2

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors.

Arribas L, Plana M, Taberna M, Sospedra M, Vilariño N, Oliva M, Pallarés N, González Tampán AR, Del Rio LM, Mesia R, Baracos V. Arribas L, et al. Among authors: vilarino n. Front Oncol. 2021 Jun 25;11:699668. doi: 10.3389/fonc.2021.699668. eCollection 2021. Front Oncol. 2021. PMID: 34249760 Free PMC article.

3

Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer.

Hijazo-Pechero S, Alay A, Marín R, Vilariño N, Muñoz-Pinedo C, Villanueva A, Santamaría D, Nadal E, Solé X. Hijazo-Pechero S, et al. Among authors: vilarino n. Cancers (Basel). 2021 Sep 22;13(19):4734. doi: 10.3390/cancers13194734. Cancers (Basel). 2021. PMID: 34638221 Free PMC article. Review.

4

Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.

Vilariño N, Bruna J, Bosch-Barrera J, Valiente M, Nadal E. Vilariño N, et al. Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7. Cancer Treat Rev. 2020. PMID: 32682248 Review.

5

Induction treatment in patients with stage III non-small cell lung cancer.

Palmero R, Vilariño N, Navarro-Martín A, Nadal E. Palmero R, et al. Among authors: vilarino n. Transl Lung Cancer Res. 2021 Jan;10(1):539-554. doi: 10.21037/tlcr-20-420. Transl Lung Cancer Res. 2021. PMID: 33569335 Free PMC article. Review.

6

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).

Nadal E, Rodríguez-Abreu D, Simó M, Massutí B, Juan O, Huidobro G, López R, De Castro J, Estival A, Mosquera J, Sullivan I, Felip E, Blasco A, Guirado M, Pereira E, Vilariño N, Navarro V, Bruna J. Nadal E, et al. Among authors: vilarino n. J Clin Oncol. 2023 Oct 1;41(28):4478-4485. doi: 10.1200/JCO.22.02561. Epub 2023 Aug 21. J Clin Oncol. 2023. PMID: 37603816 Free PMC article. Clinical Trial.

7

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities.

Hijazo-Pechero S, Alay A, Cordero D, Marín R, Vilariño N, Palmero R, Brenes J, Nadal E, Solé X. Hijazo-Pechero S, et al. Among authors: vilarino n. Clin Transl Med. 2023 Sep;13(9):e1413. doi: 10.1002/ctm2.1413. Clin Transl Med. 2023. PMID: 37735777 Free PMC article. No abstract available.

8

Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions.

Remon J, Vilariño N, Reguart N. Remon J, et al. Among authors: vilarino n. Cancer Treat Rev. 2018 Mar;64:21-29. doi: 10.1016/j.ctrv.2018.02.002. Epub 2018 Feb 8. Cancer Treat Rev. 2018. PMID: 29454155 Review.

9

Reply to E.J. Lehrer et al and J.B. De Vis et al.

Nadal E, Vilariño N, Simó M, Navarro V, Bruna J. Nadal E, et al. Among authors: vilarino n. J Clin Oncol. 2024 Mar 1;42(7):859-861. doi: 10.1200/JCO.23.02248. Epub 2023 Dec 11. J Clin Oncol. 2024. PMID: 38079584 No abstract available.

10

Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer.

Jove M, Vilariño N, Nadal E. Jove M, et al. Among authors: vilarino n. Transl Lung Cancer Res. 2019 Dec;8(Suppl 4):S364-S368. doi: 10.21037/tlcr.2019.06.06. Transl Lung Cancer Res. 2019. PMID: 32038916 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page